Prestige Consumer Healthcare
0
Funds holding %
of 6,831 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
100% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 22
12% more repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 105
6% more funds holding
Funds holding: 303 [Q2] → 322 (+19) [Q3]
2% more capital invested
Capital invested by funds: $3.6B [Q2] → $3.66B (+$69.1M) [Q3]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]
2.89% less ownership
Funds ownership: 104.64% [Q2] → 101.76% (-2.89%) [Q3]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$95
25%
upside
Avg. target
$95
25%
upside
High target
$95
25%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
DA Davidson Linda Bolton Weiser 37% 1-year accuracy 41 / 110 met price target | 25%upside $95 | Buy Maintained | 11 Nov 2024 |
Financial journalist opinion
Based on 3 articles about PBH published over the past 30 days
Neutral
Zacks Investment Research
4 days ago
PBH vs. BSX: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
Positive
Zacks Investment Research
1 week ago
Prestige Consumer Stock Up 29.9% in a Year: What's Behind the Surge?
PBH sees remarkable gains from long-term brand-building strategies and developing the e-commerce channel.
Neutral
Zacks Investment Research
2 weeks ago
PBH or BSX: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Neutral
Zacks Investment Research
1 month ago
PBH vs. BSX: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
Positive
Zacks Investment Research
1 month ago
5 Beaten-Down MedTech Stocks Set to Rebound in 2025
Investors may want to take a closer look at discounted stocks, such as MCK, HAE, ARAY, LIVN and PBH, in the present market landscape.
Positive
Zacks Investment Research
1 month ago
Should Prestige Consumer Stock Stay in Your Portfolio Right Now?
Investors remain optimistic about PBH stock due to its strong focus on brand building.
Positive
Zacks Investment Research
1 month ago
PBH or ABT: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks presents investors with the better value opportunity right now?
Positive
Zacks Investment Research
2 months ago
PBH or SYK: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Positive
Zacks Investment Research
2 months ago
PBH vs. SYK: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Neutral
Seeking Alpha
2 months ago
Prestige Consumer Healthcare Inc (PBH) Q2 2025 Earnings Call Transcript
Prestige Consumer Healthcare Inc (NYSE:PBH ) Q2 2025 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations Ron Lombardi - Chairman, President & Chief Executive Officer Chris Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer Susan Anderson - Canaccord Anthony Lebiedzinski - Sidoti & Co. Operator Good day, ladies and gentlemen, and welcome to Prestige Consumer Healthcare's Second Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Charts implemented using Lightweight Charts™